Phase I Study of concurrent weekly Docetaxel and repeated Samarium-153 Lexidronam in patients with castration-resistant metastatic prostate cancer - Tu, SM; Mathew, P; Wong, FC; Johnson, MM; Logothetis, CJ (J Clin Oncology, 2009)